(Q37863050)

24 August 2017

1 reference

title

Excess mortality for patients with residual disease following resection of pituitary adenomas (English)

1 reference

24 August 2017

1 reference

2

Edward F Chang

1 reference

24 August 2017

Michael E Sughrue

1

1 reference

24 August 2017

Rodney A Gabriel

series ordinal

3

1 reference

24 August 2017

Manish K Aghi

series ordinal

4

1 reference

24 August 2017

Lewis S Blevins

series ordinal

5

1 reference

24 August 2017

publication date

1 September 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

14

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

276-283

1 reference

Molecular defects in the pathogenesis of pituitary tumours

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Update in pituitary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Combining evidence from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Meta-analysis in the design and monitoring of clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

A nationwide survey of mortality in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Treatment outcomes and mortality of 94 patients with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Hypopituitarism and mortality in pituitary adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Morbidity and mortality in Cushing's disease: an epidemiological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Epidemiology of acromegaly in the Newcastle region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Treatment of pituitary-dependent Cushing's syndrome: long-term results of unilateral adrenalectomy followed by external pituitary irradiation compared to transsphenoidal pituitary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Radiosurgery for Cushing's disease after failed transsphenoidal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Long-term mortality after transsphenoidal surgery for Cushing disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Life expectancy following surgery for pituitary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Surgical treatment of thyrotropin-secreting pituitary adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Pituitary surgery for acromegaly. Should be done by specialists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Thyrotropin-Secreting Pituitary Adenomas: Clinical and Biochemical Heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0308-1

Determinants of clinical outcome and survival in acromegaly

21 January 2018

1 reference

12 December 2020

Long-term results of treatment of Cushing's disease by adrenalectomy

1 reference

12 December 2020

Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery

1 reference

12 December 2020

Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984

1 reference

12 December 2020

Long-term outcome of patients with acromegaly and congestive heart failure

1 reference

12 December 2020

Results of adrenal surgery for Cushing's syndrome: 10 years' experience

1 reference

12 December 2020

Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas.

1 reference

12 December 2020

Mortality in 154 surgically treated patients with acromegaly--a 10-year follow-up survey

1 reference

12 December 2020

Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results

1 reference

12 December 2020

Survival and causes of death after adrenalectomy for Cushing's disease.

1 reference

12 December 2020

Factors influencing mortality in acromegaly

1 reference

12 December 2020

Role of bilateral adrenalectomy in Cushing's disease

1 reference

12 December 2020

A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly

1 reference

12 December 2020

Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas

1 reference

12 December 2020

The survival and well-being of patients treated for Cushing's syndrome

1 reference

12 December 2020

TSH-induced hyperthyroidism caused by a pituitary tumor

1 reference

12 December 2020

Reporting on methods in clinical trials

1 reference

12 December 2020

Gamma knife radiosurgery in the treatment of Cushing disease: long-term results

1 reference

12 December 2020

Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas

1 reference

12 December 2020

An audit of outcome of treatment in acromegaly.

1 reference

12 December 2020

10.1007/S11102-011-0308-1

Identifiers

DOI

1 reference

24 August 2017

1 reference